Terms: = Lung cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1
134 results:
1. If it's a target, it's a pan-cancer target: Tissue is not the issue.
Adashek JJ; Kato S; Sicklick JK; Lippman SM; Kurzrock R
Cancer Treat Rev; 2024 Apr; 125():102721. PubMed ID: 38522181
[TBL] [Abstract] [Full Text] [Related]
2. Lactiplantibacillus plantarum K8 lysates regulate hypoxia-induced gene expression.
Jeong J; Kang BH; Ju S; Park NY; Kim D; Dinh NTB; Lee J; Rhee CY; Cho DH; Kim H; Chung DK; Bunch H
Sci Rep; 2024 Mar; 14(1):6275. PubMed ID: 38491188
[TBL] [Abstract] [Full Text] [Related]
3. Expansion of targeted degradation by Gilteritinib-Warheaded PROTACs to ALK fusion proteins.
Yokoo H; Tsuji G; Inoue T; Naito M; Demizu Y; Ohoka N
Bioorg Chem; 2024 Apr; 145():107204. PubMed ID: 38377822
[TBL] [Abstract] [Full Text] [Related]
4. DNMT3a-mediated upregulation of the stress inducible protein sestrin-2 contributes to malignant transformation of human bronchial epithelial cells following nickel exposure.
Wang X; Tian Z; He L; Meng H; Zhu J; Li Y; Wang J; Hua X; Huang H; Huang C
Ecotoxicol Environ Saf; 2024 Feb; 271():115954. PubMed ID: 38232523
[TBL] [Abstract] [Full Text] [Related]
5. PROTACs Targeting BRM (SMARCA2) Afford Selective
Berlin M; Cantley J; Bookbinder M; Bortolon E; Broccatelli F; Cadelina G; Chan EW; Chen H; Chen X; Cheng Y; Cheung TK; Davenport K; DiNicola D; Gordon D; Hamman BD; Harbin A; Haskell R; He M; Hole AJ; Januario T; Kerry PS; Koenig SG; Li L; Merchant M; Pérez-Dorado I; Pizzano J; Quinn C; Rose CM; Rousseau E; Soto L; Staben LR; Sun H; Tian Q; Wang J; Wang W; Ye CS; Ye X; Zhang P; Zhou Y; Yauch R; Dragovich PS
J Med Chem; 2024 Jan; 67(2):1262-1313. PubMed ID: 38180485
[TBL] [Abstract] [Full Text] [Related]
6. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
7. UBE3B promotes breast cancer progression by antagonizing HIF-2α degradation.
Wang Y; Liu X; Wang M; Wang Y; Wang S; Jin L; Liu M; Zhou J; Chen Y
Oncogene; 2023 Nov; 42(46):3394-3406. PubMed ID: 37783786
[TBL] [Abstract] [Full Text] [Related]
8. Selective degradation of BRD4 suppresses lung cancer cell proliferation using GSH-responsive PROTAC precursors.
Fan H; Zhou Z; Yu D; Sun J; Wang L; Jia Y; Tian J; Mi W; Sun H
Bioorg Chem; 2023 Nov; 140():106793. PubMed ID: 37683536
[TBL] [Abstract] [Full Text] [Related]
9. Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.
Tsakonas G; Tadigotla V; Chakrabortty SK; Stragliotto G; Chan D; Lewensohn R; Yu W; Skog JK; Hydbring P; Ekman S
Lung Cancer; 2023 Aug; 182():107292. PubMed ID: 37423059
[TBL] [Abstract] [Full Text] [Related]
10. Targeting of SOS1: from SOS1 Activators to Proteolysis Targeting Chimeras.
Hamilton G; Stickler S; Rath B
Curr Pharm Des; 2023; 29(22):1741-1746. PubMed ID: 37073657
[TBL] [Abstract] [Full Text] [Related]
11. Tumor heterogeneity in vhl drives metastasis in clear cell renal cell carcinoma.
Hu J; Tan P; Ishihara M; Bayley NA; Schokrpur S; Reynoso JG; Zhang Y; Lim RJ; Dumitras C; Yang L; Dubinett SM; Jat PS; Van Snick J; Huang J; Chin AI; Prins RM; Graeber TG; Xu H; Wu L
Signal Transduct Target Ther; 2023 Apr; 8(1):155. PubMed ID: 37069149
[TBL] [Abstract] [Full Text] [Related]
12. LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing vhl through a non-canonical function of EZH2.
Duan Y; Yue K; Ye B; Chen P; Zhang J; He Q; Wu Y; Lai Q; Li H; Wu Y; Jing C; Wang X
Cell Death Dis; 2023 Feb; 14(2):149. PubMed ID: 36813772
[TBL] [Abstract] [Full Text] [Related]
13. Clear cell mesotheliomas with inactivating vhl mutations and near-haploid genomic features.
Michal M; Kravtsov O; Ross JS; Skanderová D; Martínek P; Mosaieby E; Mata DA; Williams EA; Hung YP
Genes Chromosomes Cancer; 2023 May; 62(5):267-274. PubMed ID: 36515470
[TBL] [Abstract] [Full Text] [Related]
14. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
Ruggeri RM; Benevento E; De Cicco F; Fazzalari B; Guadagno E; Hasballa I; Tarsitano MG; Isidori AM; Colao A; Faggiano A;
J Endocrinol Invest; 2023 Feb; 46(2):213-234. PubMed ID: 36038743
[TBL] [Abstract] [Full Text] [Related]
15. A Novel PHD2/vhl-mediated Regulation of YAP1 Contributes to VEGF Expression and Angiogenesis.
Bora-Singhal N; Saha B; Mohankumar D; Padmanabhan J; Coppola D; Chellappan S
Cancer Res Commun; 2022 Jul; 2(7):624-638. PubMed ID: 35937460
[TBL] [Abstract] [Full Text] [Related]
16. Patients deriving long-term benefit from immune checkpoint inhibitors demonstrate conserved patterns of site-specific mutations.
Principe DR
Sci Rep; 2022 Jul; 12(1):11490. PubMed ID: 35798829
[TBL] [Abstract] [Full Text] [Related]
17. Differences in actionable genomic alterations between brain metastases and non‑brain metastases in patients with non‑small cell lung cancer.
Nian R; Jiang H; Zhao J; Hou W; Zhang H; Ma J; Lv P; Jiang L; Wang Y; Xu Y; Wu S; Lou J; Li W
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35796015
[TBL] [Abstract] [Full Text] [Related]
18. Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of vhl protein expression promotes the progression of clear cell renal cell carcinoma.
Yang W; Zhou J; Zhang Z; Zhang K; Xu Y; Li L; Cai L; Gong Y; Gong K
Int J Biol Sci; 2022; 18(6):2583-2596. PubMed ID: 35414787
[No Abstract] [Full Text] [Related]
19. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract] [Full Text] [Related]
20. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract] [Full Text] [Related]
[Next]